Position in CNSY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$279
-$10,145 QoQ
Shares Held
64
-99.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 22 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CNSY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $289,555,609 across 340 Biotechnology names. CNSY ranks #301 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,435 | $15,117,977 | |
| 3 | INCY |
Incyte Corp
|
116,069 | $13,157,581 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,094 | $12,529,412 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
402,731 | $9,697,762 | |
| 6 | EXEL |
Exelixis, Inc.
|
175,488 | $9,548,302 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $9,189,697 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in CNSY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279 | 64 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,424 | 64,112 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $19,466 | 28,472 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||